NCT04878952View on ClinicalTrials.gov

Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 26, 2021

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions
Non-small Cell Lung CancerNon-small Cell Lung Cancer Stage IIIRecurrent Non Small Cell Lung Cancer
Interventions
OTHER

Garmin Vivofit Activity Tracker

Activity tracker that is worn on the wrist.

Trial Locations (5)

17042

WellSpan Health - Lebanon, Lebanon

17201

WellSpan Health - Chambersburg, Chambersburg

17325

WellSpan Health - Gettysburg, Gettysburg

17403

WellSpan Health - York, York

17522

WellSpan Health - Ephrata, Ephrata

Sponsors

Lead Sponsor

NRG Oncology
All Listed Sponsors
collaborator

Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program (PA CURE)

UNKNOWN

lead

NRG Oncology

OTHER